When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Doença celíaca

Last reviewed: 13 Sep 2025
Last updated: 05 Mar 2025

Summary

Definition

History and exam

Key diagnostic factors

  • diarreia
  • distensão abdominal
  • dor/desconforto abdominal
  • anemia
  • Deficiência de imunoglobulina (IgA)
  • dermatite herpetiforme
Full details

Other diagnostic factors

  • história familiar
  • osteopenia/osteoporose
  • fadiga
  • perda de peso
  • retardo do crescimento pôndero-estatural
  • diabetes do tipo 1
  • doença tireoidiana autoimune
  • estomatite aftosa
  • hipoplasia do esmalte dental
  • hematomas frequentes
  • neuropatia periférica
  • ataxia
  • elevação inexplicada dos níveis de aminotransferase sérica
  • diagnóstico de comorbidade psiquiátrica
Full details

Risk factors

  • história familiar de doença celíaca
  • deficiência de imunoglobulina A
  • diabetes do tipo 1
  • doença tireoidiana autoimune
  • Síndrome de Down
  • Síndrome de Turner
  • Síndrome de Sjögren
  • doença inflamatória intestinal
  • colangite biliar primária
  • psoríase
Full details

Diagnostic tests

1st tests to order

  • imunoglobulina A-transglutaminase tecidual (IgA-tTG)
  • IgA quantitativa
  • IgG peptídeo de gliadina desamidada (DGP)
  • Hemograma completo
  • anticorpo antiendomísio (EMA)
  • biópsia de pele
  • endoscopia do intestino delgado
  • histologia do intestino delgado
Full details

Tests to consider

  • tipagem do antígeno leucocitário humano (HLA)
  • teste de provocação com glúten
  • videoendoscopia por cápsula
Full details

Treatment algorithm

ONGOING

doença celíaca

falha ao responder à terapia/doença celíaca refratária

crise celíaca

Contributors

Authors

Amelie Therrien, MD

Gastroenterologist, Celiac Center

Instructor in Medicine, Harvard Medical School

Beth Israel Deaconess Medical Center

Boston

MA

Disclosures

AT is a site principal investigator for National Institute of Allergy and Infectious Diseases NIAID (IMX003 [latiglutenase]).

Benjamin Lebwohl, MD, MS

Associate Professor of Medicine and Epidemiology

Columbia University Irving Medical Center

New York

NY

Disclosures

BL is an unpaid advisor for Nima Partners, Takeda, Teva, 9 Meters Biopharma, Bristol Myers Squibb, Mozart Therapeutics, and Alimentiv and a contractual researcher for Anokion. BL is an author of several references in this topic.

Acknowledgements

Dr Amelie Therrien and Dr Benjamin Lebwohl would like to gratefully acknowledge Professor Ciaran P. Kelly and Dr Daniel A. Leffler, previous contributors to this topic.

Disclosures

DAL declares that he has no competing interests. CPK is a scientific advisor/consultant for Cour Pharma, Glutenostics, Immunogenx, Innovate, and Takeda Pharmaceuticals. He is an investigator for Aptalis and Takeda, and has stock options in Cour Pharma and Glutenostics. CPK is also a co-author of several references cited in this topic.

Peer reviewers

Matthew Kurien, PGDip MedSci, MD, MBChB, MRCP

Senior Clinical Lecturer and Honorary Consultant Gastroenterologist

Department of Infection, Immunity & Cardiovascular Disease

Sheffield Medical School

Sheffield

UK

Disclosures

MK declares that he has no competing interests.

Eli D. Ehrenpreis, MD

Professor of Medicine

Rosalind Franklin Medical School

Chicago

IL

Disclosures

EDE declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613.Full text  Abstract

van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010 May 5;303(17):1738-46.Full text  Abstract

Chaudrey KH. ACG guideline: diagnosis and management of celiac disease. Am J Gastroenterol. 2023;118(1):23. Abstract

Husby S, Koletzko S, Korponay-Szabó I, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020 Jan;70(1):141-56.Full text  Abstract

National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. Sep 2015 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Doença celíaca images
  • Differentials

    • Duodenite péptica
    • Doença de Crohn
    • Giardíase
    More Differentials
  • Guidelines

    • Diagnosis and management of celiac disease
    • Coeliac disease: recognition, assessment and management
    More Guidelines
  • Patient information

    Doença celíaca

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer